Albireo Pharma Inc (ALBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2012 | 06-2012 | 03-2012 | 12-2011 | 09-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 39,110 | 44,751 | 31,404 | 35,112 | 38,761 |
| Receivables | 131 | 34 | 35 | 35 | 36 |
| TOTAL | $39,536 | $45,201 | $32,066 | $35,974 | $39,196 |
| Non-Current Assets | |||||
| PPE Net | 1,552 | 1,662 | 1,878 | 2,059 | 2,253 |
| Intangibles | 46 | 47 | 48 | 49 | 49 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 7 |
| TOTAL | $1,598 | $1,709 | $1,926 | $2,108 | $2,309 |
| Total Assets | $41,134 | $46,910 | $33,992 | $38,082 | $41,505 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 285 | 180 | 114 | 151 | 222 |
| Accrued Expenses | 2,394 | 2,515 | 2,503 | 3,246 | 2,964 |
| TOTAL | $2,780 | $2,768 | $2,714 | $3,502 | $3,289 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 7,338 | 7,182 | 995 | 1,141 | 1,138 |
| TOTAL | $7,338 | $7,182 | $995 | $1,141 | $1,138 |
| Total Liabilities | $10,118 | $9,950 | $3,709 | $4,643 | $4,427 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 466 | 324 | 322 | N/A |
| Common Shares | 142 | 140 | 389 | 386 | 96 |
| Retained earnings | -196,093 | -190,214 | -184,164 | -179,847 | -175,346 |
| Other shareholders' equity | 54 | 0 | 0 | 0 | 0 |
| TOTAL | $31,016 | $36,960 | $30,283 | $33,439 | $37,078 |
| Total Liabilities And Equity | $41,134 | $46,910 | $33,992 | $38,082 | $41,505 |